NCT02898454: A reported trial by Sanofi
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02898454 |
|---|---|
| Title | A Randomized, Double-blind, 52-week, Placebo Controlled Efficacy and Safety Study of Dupilumab, in Patients With Bilateral Nasal Polyposis on a Background Therapy With Intranasal Corticosteroids |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 28, 2016 |
| Completion date | Aug. 27, 2018 |
| Required reporting date | Aug. 27, 2019, midnight |
| Actual reporting date | Aug. 23, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 15, 2025 |
| Days late | None |